GXO vs RTX

GXO presents a stark contrast between deterministic value metrics and forward-looking analyst sentiment. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $57.15 trades at a massive premium to the Graham Number ($12.81) and Intrinsic Value ($1.96). However, the dramatic collapse from a trailing P/E of 204.11 to a forward P/E of 16.49 suggests a significant expected earnings recovery. While the company has a stellar 20-quarter track record of beating estimates, liquidity concerns (Current Ratio 0.85) and negative YoY earnings growth temper the bullish analyst consensus.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.